Palo Alto, Calif. - Connetics Corp., based here, plans to start clinicaltrials on a new acne drug that some reports say is "cosmetically elegant."
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Managing Food Allergies with Dupilumab in Pediatric Dermatology
Latex Gloves and the Americans With Disabilities Act